A recent study by the ICMR National Centre for Disease Informatics and Research warns of a 5.6% annual increase in Indian breast cancer cases, driven by various risk factors.

Bec Pickering, from Melbourne, has just one wish for her two young daughters after a devastating diagnosis turned her own ...

New research indicates that a long-maligned menopausal treatment is safer than previously thought, showing that it doesn’t increase breast cancer risk in women with inherited mutations in the BRCA1 or ...

Menopausal hormone therapy (MHT) does not raise breast cancer risk in women with breast cancer gene mutations, while estrogen only MHT leads to reduced risk.

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Menopausal hormone therapy did not elevate risk for breast cancer among women with inherited BRCA ...

Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited mutations in the BRCA1 or BRCA2 genes, according to the results of a matched ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

SAN ANTONIO – Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited mutations in the BRCA1 or BRCA2 genes, according to the results ...

A woman who underwent a double mastectomy at just 21 claims the decision was a 'no brainer' after learning she carries the deadly BRCA2 gene. Charlotte Hamer made the decision to be tested for the ...

A growing number of women are turning to testosterone treatments to ease their menopause symptoms — and save their sex lives.

The Phase 3 AMPLITUDE trial led by UCL found that adding the PARP inhibitor niraparib to standard hormone therapy may slow ...